Max Nisen, Bloomberg Opinion biotech, pharma and health care columnist, discusses why it's still early days for Moderna's virus vaccine. Lisa Knee, co-leader for the national real estate practice at Eisner Amper, on the commercial real estate landscape. Burt Flickinger, Managing Director at Strategic Resource Group, on why J.C. Penney will still be viable after filing for bankruptcy. Don McCree, Vice Chairman and Head of Commercial Banking at Citizens Bank, on banking and small business lending. Hosted by Lisa Abramowicz and Paul Sweeney.

Max Nisen, Bloomberg Opinion biotech, pharma and health care columnist, discusses why it's still early days for Moderna's virus vaccine. Lisa Knee, co-leader for the national real estate practice at Eisner Amper, on the commercial real estate landscape. Burt Flickinger, Managing Director at Strategic Resource Group, on why J.C. Penney will still be viable after filing for bankruptcy. Don McCree, Vice Chairman and Head of Commercial Banking at Citizens Bank, on banking and small business lending. Hosted by Lisa Abramowicz and Paul Sweeney.

Listen for investment news and in-depth company research. 

Hosts Paul Sweeney and Scarlet Fu harness the power of Bloomberg Intelligence to analyze investments on Wall Street. Watch Bloomberg Intelligence LIVE on YouTube, weekdays from 10AM to 12PM ET: http://bit.ly/3vTiACF.

Listen for investment news and in-depth company research. Hosts Paul Sweeney and Scarlet Fu harness the power of Bloomberg Intelligence to analyze investments on Wall Street. Watch Bloomberg Intelligence LIVE on YouTube, weekdays from 10AM to 12PM ET: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

Moderna Vaccine Holds Promise But In Very, VERY Early Days

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b3d07dfb-d24b-4fa8-8d44-ae3c0043a199/transcript